Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001677687-17-000001
Filing Date
2017-06-08
Accepted
2017-06-08 10:44:11
Documents
1
Period of Report
2017-04-07

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3276
  Complete submission text file 0001677687-17-000001.txt   4715
Mailing Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042
Business Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042 832-781-8521
AngioSoma, Inc. (Issuer) CIK: 0001502152 (see all company filings)

EIN.: 273480481 | State of Incorp.: NV | Fiscal Year End: 0930
SIC: 1311 Crude Petroleum & Natural Gas

Mailing Address 14001 WALDEN RD. SUITE 600 MONTGOMERY TX 77356
Business Address
Blankenship Alex K (Reporting) CIK: 0001677687 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55072 | Film No.: 17899387